Proving the Business Case for the Internet of Things

Siemens, kidney disease home testing

William Payne
November 1, 2018

Siemens Healthineers and have formed a global OEM alliance to help patients improve their compliance with Chronic Kidney Disease (CKD) monitoring.  Siemens Healthineers urinalysis reagents will be integrated into’s smartphone-based urinalysis system to provide a home testing option, enabling the broadest possible access to albumin-to-creatinine ratio testing.

The alliance is aimed at supporting the estimated 8-10 percent of the adult population globally who have some form of kidney damage. Undetected CKD can lead to kidney failure, and also increase a patient’s risk of premature death from associated cardiovascular diseases.

Regular monitoring of kidneys is important for improved patient outcomes.  Periodic urine testing to monitor kidney function is traditionally performed in a clinician’s office and can be time consuming for patients.  The Siemens Healthineers and alliance is designed to offer patients a more convenient alternative.

“Siemens Healthineers has been a leader in urinalysis testing for 75 years, enabling healthcare professionals around the world to test for chronic kidney disease and other conditions from the point of care to the central lab,” said Christoph Pedain, Executive Vice President, Point of Care Diagnostics, Siemens Healthineers. “This alliance expands our capabilities to improve patient experience by conducting testing in their home. Increased access to albumin-to-creatinine ratio testing—whether at home or at the physician’s office—is critical to reducing the economic burden of chronic disease and to improving patient outcomes.”

“ is a pioneer in using computer vision and machine learning to transform the smartphone camera into a clinical grade medical device for improved patient access and convenience. and Siemens Healthineers share a vision for a future of healthcare, which sees consumers take greater control of their healthcare in a way that complements the existing clinician workflow,” said Yonatan Adiri, Founder & CEO,